NRC
MRK icon

New Republic Capital’s Merck MRK Stock Holding History

New Republic Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47M Buy
11,402
+2,653
+30% +$311K 0.34% 60
2026
Q1 		$1.06M Sell
8,749
-3,664
-30% -$423K 0.36% 52
2025
Q4 		$1.32M Buy
12,413
+6,192
+100% +$581K 0.35% 50
2025
Q3 		$527K Buy
6,221
+452
+8% +$37.2K 0.16% 87
2025
Q2 		$461K Buy
5,769
+430
+8% +$34.2K 0.16% 88
2025
Q1 		$483K Buy
5,339
+385
+8% +$35.9K 0.21% 81
2024
Q4 		$497K Buy
4,954
+389
+9% +$40.1K 0.32% 74
2024
Q3 		$522K Buy
4,565
+88
+2% +$10.5K 0.3% 77
2024
Q2 		$558K Buy
4,477
+93
+2% +$12K 0.28% 71
2024
Q1 		$582K Sell
4,384
-365
-8% -$45K 0.37% 64
2023
Q4 		$521K Buy
4,749
+1,137
+31% +$118K 0.37% 63
2023
Q3 		$374K Buy
3,612
+22
+0.6% +$2.37K 0.31% 74
2023
Q2 		$416K Buy
3,590
+302
+9% +$34.3K 0.29% 67
2023
Q1 		$352K Buy
3,288
+634
+24% +$68.5K 0.27% 75
2022
Q4 		$296K Buy
+2,654
New +$271K 0.23% 79

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

New Republic Capital's MRK Position: Q2 2026 in Review

New Republic Capital increased its Merck (MRK) stake by 30% in Q2 2026, buying an estimated $311K and bringing the position to 11,402 shares worth $1.47M. The position accounts for 0.34% of the portfolio, ranked #60.

New Republic Capital first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • New Republic Capital held 11,402 shares of Merck worth $1.47M as of Q2 2026.
  • New Republic Capital bought 2,653 Merck shares in Q2 2026, an estimated $311K.
  • Merck made up 0.34% of New Republic Capital's portfolio in Q2 2026, its #60 holding.
  • New Republic Capital first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on New Republic Capital's 13F filing for Q2 2026, filed 31 Jul 2026.